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Antimycin AReactive oxygen species (ROS) are involved in the pathophysiology of several diseases (e.g. Alzheimer or athero-
sclerosis) and also in the aging process. The main source of ROS in aerobic organisms is the electron transport
chain (ETC) in the inner mitochondrial membrane. Superoxide is produced at complexes I and III of the ETC,
starting a complex network of ROS reactions. To achieve a deeper mechanistic understanding of how ROS
are generated by complex III, we developed a mathematical model that successfully describes experimental
data of complex III activity in various rat tissues, the production of ROS with and without antimycin and ROS
generation depending on different values of the membrane potential ΔΨ. The model also reinforces the idea of
ubiquinone acting as a redox mediator between heme bL and oxygen, as proposed earlier.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
In 1956, Harman [1] proposed that reactive oxygen species (ROS)
are at the center of the aging process. ROS, such as the superoxide
anion (O2·−), hydrogen peroxide (H2O2) or the hydroxyl radical (HO•),
are highly reactive byproducts of oxygen metabolism, and are able to
damage all biologically relevant molecules (proteins, lipids, DNA) of
the cell. The role of ROS for the aging process has been investigated in
numerous studies [2–8], but nevertheless the exact mechanisms of
ROS production and the reactions involved remain poorly understood
[9,10]. Furthermore, ROS are involved inmany diseases and play an im-
portant role as cell signaling molecules for various processes [11].
The majority of ROS are produced by the mitochondrial electron
transfer chain,more precisely by complex I (NADH:ubiquinoneoxidore-
ductase) and complex III (cytochrome bc1 complex) [12–14]. The cata-
lytic mechanism of complex III is the protonmotive Q-cycle [15]. For a
long time, a semiquinone formed as an intermediate during the oxida-
tion of ubiquinol by complex III has been postulated as the reductant
for oxygen converting it to superoxide [16–18]. However, mechanistic
studies revealed that this intermediate, if at all is only formed at veryensive-Care Medicine and Pain
niversity, Frankfurt am Main,low occupancy [19–22] rendering this mechanism very unlikely. An
alternative mechanism was deduced from the observation that the
production of ROS by antimycin A inhibited complex III increases with
the fraction of oxidized quinone reaching a maximum at about 70%
reduction of the pool, suggesting that superoxide is primarily formed
in a reverse reaction involving transient reduction of ubiquinone by
heme bL [9]. This hypothesis was supported by independent results
suggesting that reduced heme bL was required for superoxide formation
by complex III [23,24]. These two opposingmechanisms are in the focus
of an ongoing discussion (overview in [25]).
To investigate these ideas we developed a mathematical model for
complex III that describes in detail the reactions of the protonmotive
Q-cycle, the inﬂuence of the membrane potential and the production
of superoxide. The aim was to design a model that was (i) detailed
enough to reproduce the effect of the addition of various inhibitors,
changes of pH ormembrane potentialΔΨ, aswell as differentmetabolic
states (e.g. variations of protein quantities occurring in different tissues
or young vs. old organisms), and (ii) simple enough to be extended by
and incorporated into more general models.
1.1. The protonmotive Q-cycle
At complex III, the electrons are transferred fromQH2 to cytochrome
c in a sophisticated process, called protonmotive Q-cycle [15,26]. In
summary (see Fig. 1) two QH2 molecules pass through complex III,
one is oxidized to Q while the other is formally ﬁrst oxidized to Q and
Fig. 1. The protonmotive Q-cycle starts with two electrons entering complex III. QH2 gives one electron to FeS (which is eventually transferred to cytochrome c via heme c1) and a second
electron reduces heme bL. This electron is transferred to an oxidized quinone at theQi site via heme bH. The semiquinone then remains there, stabilized by bH. Next a second QH2 gives its
electrons to complex III at theQo site (as before, one goes to FeS, and one to bL); the second electron reduces the semiquinonewaiting at theQi site, which then takes up two protons from
the matrix to form QH2. The model describes superoxide production via an electron ﬂow from reduced heme bL to Q and then onto oxygen leading to the formation of superoxide [9].
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diffuses to theQo site, located at the outer side of the innermitochondri-
al membrane where it is assumed to be oxidized in a concerted mecha-
nism [20,21,27]. The ﬁrst electron goes to the “Rieske” iron–sulfur
cluster and the second to heme bL. During this reaction, two protons
are released into the inter-membrane space.
The hydrophilic domain of the reduced “Rieske” iron–sulfur protein
moves from a position near heme bL to a position near the heme center
of cytochrome c1. The electron is transferred to cytochrome c1 and the
oxidized FeS returns to its original position, ready to receive again an
electron from another ubiquinol.
Meanwhile an oxidized ubiquinone, Q, enters the Qi site, waiting to
be reduced. This becomes possible after the reduced heme bL transfers
its electron to the oxidized heme bH from where it moves onto an
oxidized ubiquinone at the Qi site. The resulting ubisemiquinone is
stabilized by bH [28], waiting for a second electron. This additional elec-
tron comes from a second ubiquinol entering theQo site, which gives its
electrons to the iron–sulfur cluster and heme bL, as in theﬁrst half-cycle.
Again the electron is passed from bL to bH and then to the semiquinone
waiting at the Qi site. This last process involves the uptake of two pro-
tons from the matrix to form a fully reduced quinone QH2.
Per round of Q-cycle, this results in the formation of two reduced
cytochrome c, together with the generation of one Q. Additionally,
four protons are released into the inter-membrane space, while two
protons are taken up from the matrix. That means just looking at
complex III only two charges cross the membrane and this is the
pump stoichiometry energetically relevant for its contribution to the
formation of the protonmotive force. The two additional protons
released to the intermembrane space by complex III are “scalar”,
i.e. they do not contribute to the vectorial charge translocation as such,
although – together with the protons taken up during reduction of
ubiquinone by the dehydrogenase – they are important to balance the
overall stoichiometry of chemical protons.
QH2 þ 2cytCox þ 2HþMX ⇌Q þ 2cytCred þ 4HþIMS:
Since the initial proposal of the protonmotiveQ-cycle [15], modiﬁca-
tions have been proposed to explain the experimental data gathered
over the years [29]. The double-gating theory has been introduced to
avoid short-circuits in the model that are not seen experimentally [30,31]. In the model presented here, we avoid short-circuits by assuming
a concerted mechanism for the quinone oxidation at complex III: QH2
releases both electrons effectively at the same time and no transfer
between bL and FeS is allowed. Reverse electron transfers (and so QH2
production at Qo) are only possible if bL and FeS are reduced.
Over the last years severalmodels of the respiratory chain have been
developed [32–35], but only a few address the question of superoxide
production by complex III [36–40]. Unfortunately, all models allow for
the presence of a semiquinone at Qo when at the same time bL is in its
reduced form. But this situation is quite improbable due to electrostatic
considerations [19]. Additionally, there are several points that render
the existing models unsuitable for us. Selivanov's model [36] comprises
more than 400 state variables representing the different electronic
conﬁgurations of complex III, making it quite complex and difﬁcult
to handle. Quinlan's model [39] focuses on Qo reactions, and only
addresses complex III inhibition by antimycin A. And Demin's model
[41,38] not only considers the quinone oxidation at the Qo site as a
two step reaction, but also omits the existence of a semiquinone at the
Qi site.
A recent, thermodynamically consistent, simple model with only
6 state variables [40] could be nicely ﬁtted to experimental data of
turnover rates of the bc1 complex. However, its simplicity makes it
unsuitable to test our hypothesis, since the positions of electrons at
the Qo site are not determined.
Thus, we developed a newmodel to set a different focus and to avoid
some shortcomings of previous models. Precisely, we incorporated
the hypothetical mechanismof ROS production by complex III involving
reverse electron transfer from heme bL to oxygen via oxidized ubiqui-
none [9].2. Material and methods
2.1. Units
All concentrations are expressed in mol per L. The kinetic constant
units depend on the reactions considered: mol1 − A · LA − 1 · s−1,
with A the sum of the orders of the species. ΔΨ is in mV, with ΔΨ=
ΨIMS − ΨMX, where IMS denotes inter-membrane space, and MX the
matrix.
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The components taken into account in the model are: complex III,
cytochrome c and the quinone pool. All other components of the respi-
ratory chain are not in the scope of this study.
In order to keep themodel tractable, we focus on the following three
centers of complex III: the iron–sulfur cluster (FeS), heme bL and heme
bH. Heme c1 has been neglected.
The following notation is introduced to describe the reactions taking
place in the model. The different centers of complex III (FeS, bL, bH) can
be in two different states: reduced (r) or oxidized (o). The symbol *
stands for any of the two possible states. For example, CIII(r,o,*) refers
to a conﬁguration of complex III with FeS reduced (r), bL oxidized (o),
and bH reduced or oxidized (*). Furthermore, the subscript “MX” indi-
cates a matrix location while “IMS” indicates the inter-membrane
space. Using this notation the model can be described by the following
six equations.
1. Reduced ubiquinone transfers its two electrons to complex III, if both
FeS and bL are oxidized:
CIII o;o; ð Þ þ QH2⇌ CIII r; r; ð Þ þ Q þ 2HþIMS:
2. Heme bL passes its electron to heme bH, if heme bH is oxidized:
CIII ; r;oð Þ⇌ CIII ;o; rð Þ:
3. At the Qi site, one electron is transferred from reduced heme bH (bH· )
to oxidized quinone (Q). The resulting semiquinone then forms a sta-
bilizing complexwith heme bH by sharing its electron. This stabilized
state is indicated in the equation by dots.
CIII ; ; rð Þ þ Q ⇌ CIII ; ; oð Þ⋯Q −:
4. At the Qi site, (bH· ) can also give one electron to a semiquinone (Q·−)
if it is present. Twoprotons from thematrix are consumed toproduce
QH2:
CIII ; ; rð Þ⋯Q − þ 2HþMX ⇌ CIII ; ; oð Þ þ QH2:
5. Reduced FeS transfers its electron to oxidized cytochrome c:
CIII r; ; ð Þ þ cytC⇌ CIII o; ; ð Þ þ cytC:
6. As proposed [9] reduced heme bL (bL·) may donate one electron to
Q to transiently produce Q·− at the Qo site that is then oxidized by
O2 to generate superoxide (O2·−):
CIII ; r; ð Þ þ Q ⇌ CIII ;o; ð Þ þ Q −
Q − þ O2→Q þ O−2 :
The constants for the six reactions are k1 to k6 (forward reactions)
and k−1 to k−6 (backward reactions), respectively. In our model com-
plex III has sixteen possible electronic conﬁgurations, A–P (see Fig. 2);
eight for complex III alone, and eight for complex III bound to Q·−.
This leads to the model structure presented by Fig. 2.
In ourmodel the concentrations of some variables are kept constant.
This holds for the membrane potential ΔΨ, the oxygen concentration,
cytochrome c aswell as the ratio of oxidized vs. reduced quinone. There-
fore the total rate of cytochrome c reduction can be calculated by the
summation of all ﬂuxes involving reaction 5 and the rate of superoxide
production is calculated by summing up all ﬂuxes involving reaction 6.
The explicit system of ODEs is given in Appendix A.2.3. Modeling antimycin A inhibition
Antimycin A is an inhibitor of complex III, commonly used to study
details of ROS generation at this complex. It binds complex III at the Qi
site, preventing the quinone to enter this site. In the presence of
antimycin A, electrons are accumulating at hemes bL and bH. The reduc-
tion of quinone at the Qo site by heme bL is then favored [9] leading to
superoxide formation. In modeling terms this means that reactions 3
(forward) and 4 (backward) are blocked during antimycin A treatment.
2.3.1. Inhibition of cytochrome c reduction by an occupied Qi site
Recently a mechanism has been proposed to explain the phenome-
non that the rate of complex III changes if the Qi site is occupied by
a molecule [42]. This idea provides a mechanistic basis for early postu-
lates that the antimycin A binding site and the Rieske protein are
conformationally linked [43,44]. It is known that the Qi and Qo sites
are connected via a helix. The author hypothesized that the movement
of FeS from heme bL to cytochrome c1 is inﬂuenced by this helix. If the
helix is mobile, then FeS can move freely, but if the helix is ﬁxed, the
movement of FeS is restricted. If the Qi site is not occupied, the helix is
mobile, but if Qi is occupied by antimycin A or a semiquinone attached
near heme bH, the helix is ﬁxed and the movement of FeS is restricted.
To incorporate this idea in the model, the rate constants k5 and k−5
are modiﬁed by inhibk5 in the presence of antimycin A or of a stabilized
semiquinone at the Qi site:
k05 ¼ k5  inhibk5; for CIII ; ; ð Þ⋯Q −½ 
k05 ¼ k5; else
(
ð1Þ
and
k0−5 ¼ k−5  inhibk5; for CIII ; ; ð Þ⋯Q −½ 
k0−5 ¼ k−5; else
(
ð2Þ
2.3.2. Effect of the oxidation state of heme bH
In a previous model, the effects of the oxidation state of heme bH on
ROS production were modeled, if complex III is inhibited [39]. A factor
was used to slow down the oxidation of the semiquinone at the Qo
site when heme bH is reduced. In our model we implemented a similar
mechanism by applying an inhibition (via inhibk6) to reaction 6
(semiquinone formation with an electron from heme bL, see Fig. 2) for
those species of complex III that have a reduced heme bH (species D,
H, J and N). The same formalism was applied as for the inhibition of
reaction 5 (see Eqs. (1) and (2)).
2.4. Equations of the model
Every electron transfer is modeled using mass-action kinetics, the
global rate υ of the reaction is:
υ ¼ kf ∏
i
Si½ ni−kb∏
j
P j
h in j ð3Þ
where ni and nj denote the respective molecularities of substrates and
products in this reaction. The transfer of electrons between bL and bH
(reaction 2) is the only reaction signiﬁcantly inﬂuenced by ΔΨ [29].
Therefore we deﬁne new rate constants, k2,ΔΨ and k−2,ΔΨ, which
depend on the value of ΔΨ according to [45] and [46]:
k2;ΔΨ ¼ k2  e−δ α 
ΔΨ F
RT ð4Þ
k−2;ΔΨ ¼ k−2  eδ  1−αð Þ
ΔΨ F
RT : ð5Þ
ForΔΨ=0 these expressions simplify to k2 and k−2. δ is the fraction
of themembrane potential that affects the transfer, and α is the fraction
Fig. 2.Model of complex III. The 16 electronic conﬁgurations of complex III (A to P) are depicted as rectangles with three boxes, representing the redox-centers. The dots next to the center
represent the presence (or absence) of an electron. The states I to P contain a semiquinone stabilized at the Qi site. The six electron transfers of the model (see text) are represented by
arrows and labeled with numbers. 1: reduction of complex III by QH2 (two electrons are transferred); 2: transfer of the electron from heme bL to heme bH (dotted arrows); 3: reduction
of quinone at Qi; 4: ﬁnal reduction of Q· − at Qi (dashed arrows); 5: reduction of cytochrome c by FeS. 6: transient production of semiquinone at Qo site and reduction of oxygen.
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0.5, considering that the membrane potential affects both forward and
backward reactions equally. δ is set to 0.8, as reaction 2 is the major
reaction affected by ΔΨ. The effect of ΔΨ on the reactions 1, 3 and 4
were neglected after testing the same equation with δ equal to 0.1.2.5. Parameterizing the model
To perform actual simulations of the model, numerical values have
to be assigned to the various parameters. This is done in a three-step
procedure.
In the ﬁrst approximation rate constants for reactions 1 to 6 (which
have a suitable kinetics) are calculated using electron tunneling rate
equations [47,48]. This provides starting values for the next step that
are in a physiologically relevant area of the parameter space.
In a second phase, these parameter values are optimized using the
genetic ﬁtting algorithm of Copasi [49] (number of generations: 2000;
population size: 200; random number generator: 1; seed: 0) followed
by a local algorithm (Levenberg and Marquardt; iteration limit 200;
tolerance: 1 × 10−5) of Copasi.
The parameters were ﬁtted to experimental data [50] consisting
of respiration rates for complex III during state 3 as well as quinone
and cytochrome c ratios (reduced to total quantities).Finally, rate constants were also ﬁtted to a set of experimental data
obtained in the presence of antimycin A [39]. The ﬁtting procedure
was repeated and generated a second set of parameters.
The parameters kf,6 and kr,6 (reduction of quinone by bL) are then
injected into the ﬁrst model (no antimycin A) and to calculate ROS
production. They had no effect on the previous ﬁt.
The ﬁnal parameter values are summarized in Table 1.
3. Results
3.1. Rate of complex III during state 3 respiration
The respiratory rates of coupled mitochondria were measured dur-
ing state 3 respiration in various organs of the rat: muscle, heart, liver,
kidney, and brain [50]. Additionally, the fractions (reduced species to
total species) and absolute quantities of quinone and cytochrome c
were measured, together with the amount of complex III. Considering
that these experimental data were obtained under steady-state condi-
tions, the rate of respiration (oxygen consumption by complex IV),
corresponding to the rate of cytochrome c oxidation by complex IV
(four cytochrome c for one O2), can be converted into a rate of produc-
tion of reduced cytochrome c by complex III. We used these data to ﬁt
the model parameters. The results are presented in Fig. 3. Except for
liver the ﬁt is in good agreement with the experimental results. Since
Table 1
Parameters of themodel together with a short description and the values obtained afterﬁtting to experimental data. Two sets ofﬁtted values are given, one obtainedwithout any inhibitor
[50] and one obtained in the presence of antimycin A [39].
Name (units) Description Values after ﬁtting
no Ant. A w. Ant. A
kf,1 (M−1 s−1) Rate constants for QH2 oxidation at Qo 2.8 × 1011 1.0 × 104
kr,1 (M−3 s−1) 6.2 × 1012 8.7 × 1010
kf,2 (s−1) Rate constants for electron transfer from bL to bH 7.6 × 108 1.1 × 103
kr,2 (s−1) 2.9 × 103 3.8 × 101
kf,3 (M−1 s−1) Rate constants for the ﬁrst Q reduction at Qi 2.0 × 1011 0
kr,3 (s−1) 1.3 × 1010 –
kf,4 (M−2 s−1) Rate constants for the second Q reduction at Qi 4.2 × 1018 –
kr,4 (M−1 s−1) 4.5 × 10−3 0
kf,5 (M−1 s−1) Rate constants for the cyt c reduction by complex III 2.0 × 104 2.2 × 106
kr,5 (M−1 s−1) 9.8 × 102 6.5 × 103
kf,6 (M−1 s−1)⁎ Rate constants for the reduction of the quinone by bL 4.9 × 106 4.9 × 106
kr,6 (M−1 s−1)⁎ 4.0 × 109 4.0 × 109
kf,7 (M−1 s−1)⁎⁎ Rate constant for the production of superoxide 2.2 × 107
inhibk5
⁎⁎⁎ Inhibition factor for cyt c reduction 6.0 × 10−1
inhibk6 Inhibition factor for quinone reduction at Qo 1 4.8 × 10
−1
⁎ These values are obtained from the second optimization procedure. They are then injected into the model without antimycin A; see text.
⁎⁎ This value has been calculated using the electron tunneling equation; see text.
⁎⁎⁎ This value applies only when quinone or antimycin A is present at Qi; see text.
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bolic enzymes and most notably by microsomes that contain large
amounts of cytochrome P450 monooxygenases this deviation may
reﬂect an experimental artifact.
Fig. 4A summarizes the results of a typical simulation. The three cen-
ters of complex III can each exist in a reduced or oxidized state. Further-
more, heme bH can either be associated with a semiquinone or not,
resulting in a total of 16 different states, numbered from A to P. Arrows
indicate the different reactions occurring between these states, where
the type of arrow reﬂects towhich of the six general reactions it belongs.
The reaction type is also indicated by a number next to the arrow.
The thickness of the arrows indicates the magnitude of the ﬂux
through this reaction and a dark background indicates the states with
a high steady state occupancy (states without a background have a con-
centration approaching 0). It can be seen that a reduction of FeS and
heme bL (reaction 1) occurs mainly if no semiquinone is attached to
the complex (see Fig. 4).
3.2. Complex III inhibition by antimycin A
Antimycin A is a common inhibitor used in studies of complex III
function and its production of ROS. The presence of antimycin A pre-
vents the binding of quinone at the Qi site. In the model, the effects
of antimycin A treatment are simulated by completely inhibiting the
forward rate of reaction 3 (formation of semiquinone at the Qi site)
and the backward rate of reaction 4 (production of ubiquinol at the Qi
site) (see Fig. 2). We simulated the effects of a complete inhibition ofFig. 3. Comparison of experimental data [50] and model output after ﬁtting. The model
(gray bars) was ﬁtted to state 3 electron transfer rates (white bars) for different organs
of the rat. pHIMS was set to 7.1, pHMX to 7.2 and ΔΨ to 150 mV.complex III by antimycin A, since a partial inhibitionwould lead to reac-
tion shortcuts between the two complex III molecules forming a com-
plex III homodimer [51]. The simulation shows that the concentrations
of species I to P and the rates of reactions 3 and 4 drop to zero under
antimycin A treatment (Fig. 4B).
3.3. The ratio of reduced to total Q
It has been shown experimentally that during antimycin inhibition
the ratio of reduced quinone to total quinone has a large inﬂuence on
the ROS production rate [39,9]. ROS generation is maximal at an inter-
mediate fraction and is minimal if the Q-pool is fully oxidized or
reduced.
Our model simulations show that the antimycin dependent param-
eter modiﬁcation, which we introduced in Section 2.3.1, is essential to
reproduce the “bell-shaped” curve describing the dependency of ROS
production on the ratio of reduced quinone. The model provides an ex-
cellent ﬁt to the ROS generation data (Fig. 5), and also to the measured
values for the ratio of reduced bL (Fig. 5B). Data points are shown as
crosses and the results of our ﬁtted model are shown as a continuous
line in the diagrams.
3.3.1. ROS production during antimycin treatment
Fig. 4B shows theﬂuxes and steady state concentrations of thediffer-
ent states of complex III during antimycin A treatment. The total ﬂux,
and thus the reduction rate of cytochrome c is greatly reduced and the
remaining ﬂux is concentrated along the reactions shown in red.
Thus, according to themodel simulations the production rate of ROS
should be equal to the rate of cytochrome c reduction under this condi-
tion. Of course this only holds for the rate of cytochrome c reduction by
slow turnover of the Qo site occurring, when electrons leak onto oxygen
fromheme bL, and not the rate of cytochrome c reduction resulting from
possible reactions with superoxide. A previous work showed that the
antimycin A resistant cytochrome c reduction can only be partially
suppressed by the addition of excess superoxide dismutase (SOD)
[17], indicating that superoxide dependent aswell as independent path-
ways are involved in cytochrome c reduction under these conditions.
Our simulations differ from these results, since the model does not
include a reaction between cytochrome c and superoxide. If it were
included, 50% of the cytochrome c reductionwould stem froma reaction
with superoxide and could thus be abolished by SOD. This agrees rea-
sonablywell with the 35% observed experimentally [17]. The discrepan-
cies here may be due to short-circuits occurring at low rate that are
ignored by this model.
Fig. 4. States of complex III and the protonmotive Q-cycle during (A) state 3 respiration and (B) antimycin A inhibition. The states with the highest steady state occupancy, as well as the
reactions with the highest ﬂux are highlighted in color. Occupancies/rates shown in red are about ten times higher than those shown in yellow.
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ΔΨ not only plays a central role in ATP generation, apoptosis and
mitophagy [52], but also greatly inﬂuences ROS production. After we
conﬁrmed that our model can reproduce experimental ﬁndings very
well for ΔΨ = 0 (Fig. 5), we next calculated ROS generation rates
with and without antimycin A for values of ΔΨ ranging from 0 to
250 mV (Fig. 6).
The calculated ROS production exhibits an exponential dependence
on ΔΨ if complex III is not inhibited by antimycin A. This dependence
is the direct result of the modulation of the rate of reaction 2 by ΔΨ,
and the fraction of reduced bL. This is qualitatively and quantitatively val-
idated by independent experimental data, where superoxide productionis measured against membrane potential [53]. Both, model calculations
and experimental data exhibit a 4-fold increase in ROS production
(from 6.2 · 10−7 to 2.6 · 10−6 mol s−1 for the model) for a rise in ΔΨ
from 150 to 200 mV (Q ratio = 0.05). In addition, the simulations
show that this effect is most pronounced for small fractions of reduced
quinone, i.e. for fractions that are also biologically relevant [50]. Under
these conditions the concentration of oxidized quinone atQo is especially
high, maximizing the reaction rate between reduced bL and quinone.
But ΔΨ has no inﬂuence on the ROS production if complex III is
inhibited by antimycin A. Under this condition the ﬂux of electrons
from bL to bH is practically blocked and since this is the place where
ΔΨ exerts its effect, antimycin A diminishes the effect of the membrane
potential on the ROS production.
Fig. 5.Comparison of experimental data [39] (Fig. 1) and themodel output after parameterﬁtting. TheROSproduction rate (left) and fraction of reducedheme bL (right) as a function of the
fraction of reduced quinone is shown. The substrate concentrations of the experimental data were converted to levels of reduced quinone using the Nernst equation. An apparent E0 was
determined for glutamate/malate assuming that maximal ROS production occurred at the same Q ratio for both conditions.
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We present a model of the electron transfers inside complex III,
featuring ROS production and concerted electron transfer at the Qo
site, which is mathematically tractable and is in good quantitative
agreement with experimental results.
Furthermore, themodel can simulate complex III under normal con-
ditions aswell as under inhibition by antimycin A and in the presence of
an increasing membrane potential.Fig. 6. Calculation of ROS production as a function of ΔΨ and the fraction of reduced
quinone,without (top) andwith antimycin A (bottom). Since antimycin A blocks the elec-
tron transfer from bH to ubiquinole, the membrane potential has practically no inﬂuence
on the radical production.4.1. Simpliﬁcations
To keep the mathematical description compact and tractable a
couple of simpliﬁcations were applied to reduce the number of possible
states of complex III.
Several earlier models assume a sequential, two step, mechanism at
theQo site [39,36,54,48]. This can lead to states that are unlikely to exist,
such as the presence of a semiquinone at Qo close to a reduced heme bL
[19]. So far such a semiquinone has only been observed under very arti-
ﬁcial conditions [55,56] that are not relevant for our model. Therefore,
complex III reduction by QH2was assumed to be a (quasi) concerted re-
action. This approach has the added beneﬁt that it eliminates shortcut
reactions that would have to be considered otherwise (see [30,31]).
The competition of different quinone species for the Qo site has not
been implemented in the present model, since this would greatly
increase the number of possible states. Already a distinction between
free or occupied by either QH2 or Q would lead to 48 possible states.
4.2. Parameter choice
To reproduce the different data sets, two sets of parameters were
used, one for normal complex III behavior and one for complex III
inhibited by antimycin A. This distinction between a “normal” model
and an “antimycin”modelwas expected, since antimycin A is suspected
to change the electron transfer kinetics within complex III.
4.3. Quinone and ROS production
Our model probes the concept that oxidized quinone is needed as a
redox mediator between heme bL and molecular oxygen. Even without
the formation of a semiquinone during the reduction of complex III by
QH2, the presented model is able to reproduce the bell-shape curve of
the ROS production rate with antimycin A, and the rate of cytochrome
c reduction during state 3 of respiration.
The curves for ROS production during antimycin A treatment as
given by [9] and [39] are similar (i.e. bell shaped) but their maximum
is seemingly at a different quinone ratio (70% vs. 30%). However, after
converting the substrate concentrations given by [39] (Fig. 1) into frac-
tions of reduced quinone using the Nernst equation, it turns out that
both studies ﬁnd a maximum ROS generation at 70% reduced quinone.
For our modeling study we chose the data set that contained more
data points [39].
The model simulations show that the level of semiquinone always
remains very low in comparison to other model species (with and
without antimycin A). For instance, the semiquinone steady state level
is roughly 1000 times lower than the total quinone concentration
(between 10−9 and 10−7 M depending on the experiments, vs.mM for
the other quinones). Thus, our model is in agreement with experiments
1650 F. Guillaud et al. / Biochimica et Biophysica Acta 1837 (2014) 1643–1652where no, or only in extreme situations, semiquinone was detected at
the Qo site.4.4. Role of ΔΨ in ROS production
The membrane potential plays an important role for the respiratory
chain and in the mitochondrial metabolism. Its value affects the rate of
ATP production and for extremely high values can even lead to a reverse
electron ﬂow in the respiratory chain complexes [57]. Additionally,
it has been recently shown that mitochondria with low ΔΨ are more
likely to be degraded by mitophagy [58].
We used this model to explore the effects of ΔΨ on ROS production
under various conditions, especially regarding the fraction of reduced
quinone. Fig. 6 shows the rate of ROS generation as a function of ΔΨ
and the fraction of reduced ubiquinone under normal conditions and
during inhibition by antimycin A.
Without antimycin A, ROS generation at complex III is proportional
to the fraction of reduced quinone, but is mostly controlled by ΔΨ
(exponential increase with ΔΨ), which agrees well with experimental
data [53]. With antimycin A treatment the situation is different in that
ΔΨ is much less inﬂuential in controlling ROS generation. Antimycin A
blocks the ﬂow of electrons from bH to ubiquinole, leading to the accu-
mulation of reduced bH. Since the ﬂow of electrons from bL to bH is the
main reaction inﬂuenced by the membrane potential, ROS production
is largely independent of the ΔΨ under antimycin A treatment. Instead,
under this condition it is the fraction of reduced quinone that plays the
major role in controlling ROS production.
Most of themitochondria in thedifferent organs of the rat have a low
fraction of ubiquinol [50]. This prevents superoxide formation by com-
plex III in the presence of antimycin A. But without antimycin A, a low
ubiquinol fraction together with an increase of ΔΨ leads to a rise of
the superoxide production. Since superoxide released from the Qo site
into the inter-membrane space has been proposed to be involved in
ROS signaling, in particular under conditions of pharmacological and
hypoxic preconditioning [59–62], this observation has two important
implications, namely that ROS signaling by complex III exponentially
increases with ΔΨ, but also critically depends on the redox state of
the ubiquinone pool. Remarkably, at a given membrane potential ROS
production is maximal with a low fraction of reduced ubiquinone and
approaches very low levels if the Q-pool is fully reduced.5. Conclusion
Our model studies the electron ﬂow inside complex III that leads to
ROS production.
The model reinforces the hypothesis that superoxide formation by
complex III involves ubiquinone as a redox mediator between cyto-
chrome bL and oxygen [9]. In particular, no semiquinone intermediate
of the protonmotive Q-cycle at the Qo site is required to reproduce the
experimental data.
We also implemented the idea that interactions between antimycin
A and complex III lead tomodiﬁcations of the electron transfers far from
the Qi site where antimycin A acts. This lead to simulation results that
agree very well with experimental ﬁndings. However, the molecular
mechanisms for such an interaction remain to be elucidated. These
may be mechanical, as proposed by [42], or electronic [39].Acknowledgements
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The model shown in ﬁg. 2 leads to the following system of 16
coupled ordinary differential equations, which are based on reversible
mass action kinetics.
dA
dt
¼− kf ;1A QH2−kr;1 F Q Hþ
2
IM
 
þ kf ;4I Hþ
2
x −kr;4A QH2
 
þ kf ;5E cytCox−kr;5A cytCred
 
þ kf ;6B Q−kr;6A Q •
 
ð1Þ
dB
dt
¼− kf ;2B−kr;2C
 
þ kf ;4 J Hþ
2
x −kr;4B QH2
 
þ kf ;5 F cytCox−kr;5B cytCred
 
− kf ;6B Q−kr;6A Q
•
 
ð2Þ
dC
dt
¼− kf ;1C QH2−kr;1H Q Hþ
2
IM
 
þ kf ;2B−kr;2C
 
− kf ;3C Q−kr;3K
 
þ kf ;5G cytCox−kr;5C cytCred
 
þ kf ;6D Q−kr;6C Q •
 
ð3Þ
dD
dt
¼− kf ;3D Q−kr;3L
 
þ kf ;5H cytCox−kr;5D cytCred
 
− kf ;6D Q−kr;6C Q
•
  ð4Þ
dE
dt
¼ kf ;4M Hþ
2
x −kr;4E QH2
 
− kf ;5E cytCox−kr;5A cytCred
 
þ kf ;6 F Q−kr;6E Q •
 
ð5Þ
dF
dt
¼ kf ;1A QH2−kr;1 F Q Hþ
2
IM
 
− kf ;2 F−kr;2G
 
þ kf ;4N Hþ
2
x −kr;4 F QH2
 
− kf ;5 F cytCox−kr;5B cytCred
 
− kf ;6 F Q−kr;6E Q
•
 
ð6Þ
dG
dt
¼ kf ;2 F−kr;2G
 
− kf ;3G Q−kr;3O
 
− kf ;5G cytCox−kr;5C cytCred
 
þ kf ;6H Q−kr;6G Q •
 
ð7Þ
dH
dt
¼ kf ;1C QH2−kr;1H Q Hþ
2
IM
 
− kf ;3H Q−kr;3P
 
− kf ;5H cytCox−kr;5D cytCred
 
− kf ;6H Q−kr;6G Q
•
 
ð8Þ
dI
dt
¼− kf ;1I QH2−kr;1N Q Hþ
2
IM
 
þ kf ;2L−kr;2I
 
− kf ;4I H
þ2
x −kr;4A QH2
 
þ kf ;5M cytCox−kr;5I cytCred
 
þ kf ;6 J Q−kr;6I Q •
 
ð9Þ
dJ
dt
¼− kf ;4 J Hþ
2
x −kr;4B QH2
 
þ kf ;5N cytCox−kr;5 J cytCred
 
− kf ;6 J Q−kr;6I Q
•
 
ð10Þ
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dt
¼− kf ;1K QH2−kr;1P Q Hþ
2
IM
 
þ kf ;3C Q−kr;3K
 
þ kf ;5O cytCox−kr;5K cytCred
 
þ kf ;6L Q−kr;6K Q •
 
ð11Þ
dL
dt
¼− kf ;2L−kr;2I
 
þ kf ;3D Q−kr;3L
 
þ kf ;5P cytCox−kr;5L cytCred
 
− kf ;6L Q−kr;6K Q
•
 
ð12Þ
dM
dt
¼ kf ;2P−kr;2M
 
− kf ;4M H
þ2
x −kr;4E QH2
 
− kf ;5M cytCox−kr;5I cytCred
 
þ kf ;6N Q−kr;6M Q •
 
ð13Þ
dN
dt
¼ kf ;1I QH2−kr;1N Q Hþ
2
IM
 
− kf ;4N H
þ2
x −kr;4 F QH2
 
− kf ;5N cytCox−kr;5 J cytCred
 
− kf ;6N Q−kr;6M Q
•
 
ð14Þ
dO
dt
¼ kf ;3G Q−kr;3O
 
− kf ;5O cytCox−kr;5K cytCred
 
þ kf ;6P Q−kr;6O Q •
 
ð15Þ
dP
dt
¼ kf ;1K QH2−kr;1P Q Hþ
2
IM
 
− kf ;2P−kr;2M
 
þ kf ;3H Q−kr;3P
 
− kf ;5P cytCox−kr;5L cytCred
 
− kf ;6P Q−kr;6O Q
•
  ð16Þ
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